Abstract

Immediately after the outbreak of the SARS-CoV-2 epidemic (which had risen to the level of a pandemic according to the World Health Organization), the question arose whether or not to update the risk assessment, which, as required by Legislative Decree 81/2008, with the consequent updating of the prevention measures. In light of these forecasts, we asked ourselves whether the risk of coronavirus infection should be taken into account by the employer by updating the risk assessment or not. An in-depth analysis of current legislation has led to the conclusion that the biological risk from SARS-CoV-2 is to be considered specific only in health-related activities, in other activities it can be considered exclusively generic or generic aggravated. The Risk Assessment Document can therefore only be integrated.

Highlights

  • In December 2019, several cases of atypical pneumonia were detected in the city of Wuhan, Hubei Province in inland China

  • The first patients, it will be discovered later, had shown symptoms at the beginning of December, or even in mid-November. It is on the last day of the year 2019, in a 41-year-old patient admitted 5 days earlier, that doctors officially identify a new virus called SARS-CoV-2 as the cause of this atypical pneumonia [1]

  • The initial outbreak took on considerable proportions first in China and spread to the rest of the world; on 11 March 2020, the World Health Organization (WHO) declared that the new coronavirus SARS-CoV-2 infection can be considered a pandemic [2]

Read more

Summary

INTRODUCTION

In December 2019, several cases of atypical pneumonia were detected in the city of Wuhan, Hubei Province in inland China. Group 2 biological agent: an agent that can cause disease in human subjects and pose a risk to workers; it is unlikely to spread to the community; effective prophylactic or therapeutic measures are usually available;. Group 3 biological agent: an agent that can cause serious illness in human subjects and constitutes a serious risk to workers; the biological agent can spread in the community, but effective prophylactic or therapeutic measures are usually available;. After the outbreak of the epidemic (which had risen to the level of a pandemic according to the World Health Organization), the problem arose as to whether or not the risk assessment should be updated, which, as provided for in Article 29, paragraph 3, of Legislative Decree no. In the light of these predictions, it was questioned whether the risk of coronavirus infection should be taken into account by the employer by updating the risk assessment already carried out and the related document

DISCUSSION
Findings
CONCLUSIONS
DATA AVAILABILITY STATEMENT
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.